Correction to “A Pilot One and Two‐Year Prospective, Blinded Clinical Evaluation of Efficacy, and Safety of Combined Treatment With Crosslinked Hyaluronic Acid Dermal Filler and Barbed Polydioxanone Suspension Threads for Mid‐Face Contour Enhancement”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsFacial Rejuvenation and Surgery Techniques · Reconstructive Facial Surgery Techniques · Facial Nerve Paralysis Treatment and Research
Wan J., Park H. J., Choi H.‐S., and Yi K.‐H . A pilot one‐ and two‐year prospective, blinded clinical evaluation of efficacy, and safety of combined treatment with crosslinked hyaluronic acid dermal filler and barbed polydioxanone suspension threads for mid‐face contour enhancement. J Cosmet Dermatol. 2025;24(2):e16700.39692727 10.1111/jocd.16700PMC11845956
On page 6 of 7, in the “Conflicts of Interest” section, the statement “The authors declare no conflicts of interest.” was incorrect. It should have read: “Conflicts of Interest: All authors have served as clinical advisors to JETEMA Co., Ltd. (Korea), the manufacturer of e.p.t.q. fillers and the provider of epiticon threads.”
We apologize for this error.